with an early seizure onset and cognitive impairment. Seizures often occur in clusters and are often provoked by fever. With the expansion of phenotypic spectrum in PCDH19 mutation patients, some patients do not have severe intellectual disability. Subsequent studies highlighted that most patients had focal epilepsy clusters triggered by fever, so "PCDH19 girls clustering epilepsy" (Homan et al., 2018; Vlaskamp et al., 2019) (PCDH19-GCE) was proposed as a name to facilitate clinical identification of this disorder.
The reported PCDH19 mutations were mostly located at exon 1 (Depienne et al., 2011; Leonardi et al., 2014) , which encodes the entire extracellular domain. About one-half of the reported mutations leading to PCDH19-related diseases are nonsense, frameshift, and splicing mutations, which severely truncate the protein protocadherin 19 (PCDH19). The remaining are missense mutations, and the missense mutations are concentrated in the extracellular domain of the protein (Kolc et al., 2019) . The extracellular domain is essential for the normal function of the original cadherin function (Gerosa, Francolini, Bassani, & Passafaro, 2019) . PCDH19 is mainly expressed in nerve tissues at different developmental stages, but its specific function is still unclear.
Studies have shown that the function of PCDH19 may be related to neuronal connections and signal transduction on synaptic membranes (Duszyc et al., 2015) . PCDH19 mutation may lead to protein dysfunction.
In this study, we have screened 152 children with fever-sensitive epilepsy and found PCDH19 mutation in 10 female probands who also had cluster seizures with or without cognitive impairment or mental retardation in order to further understand the clinical and mutational features of PCDH19-GCE.
| ME THODS

| Subjects
We analyzed fever-sensitive epilepsy children with the onset age 0-14 years between 2015 and 2019 in the Pediatrics Department 
| RE SULTS
| Genetic analyses
We screened 152 children with fever-sensitive epilepsy for gene detection (85 male and 67 female). We found eight PCDH19 point mutations and one whole gene deletion, four novel and four reported mutations in 10 female probands who also had cluster seizures (10/152, 6.57%) ( Table 1 and Figure 1 ). Seven mutations were located in exon 1 and one in exon 6. Two missense mutations 
| Clinical features
The follow-up period ranged from 2 months to 4 years. The onset age of 152 children ranged from 6 days after birth to 7 years old. Twenty "Cellular interference" mechanism is the main hypothesis to explain this particular genetic pattern. This hypothesis speculates that in normal women without PCDH19 mutation, cells only express wild-type PCDH19, which ensures that the organism is in a homozygous neural network environment without pathogenicity.
| D ISCUSS I ON
When individuals express two different PCDH19 in heterozygous mutation, the normal interaction between cells will be disturbed.
Males did not develop the disease because they expressed only one type of PCDH19 (mutant or wild type). found. The genetic pattern was consistent with the hypothesis of cell interference mechanism.
PCDH19-GCE is caused by PCDH19 mutations, and the protein PCDH19 which encoded by PCDH19 is expressed in various embryonic and human tissues (Cooper et al., 2015) , including kidney, lung, and trachea, but it is significantly expressed in the nervous system, especially in limbic system (such as amygdala, hippocampus, and ventral hypothalamus) and cortex (Hertel, Redies, & Medina, 2012; Kim et al., 2010; Pederick et al., 2016; Schaarschuch & Hertel, 2018) , and acts on the proliferation of progenitor cells and formation of nerve circuits and regulation of nerve activity (Bassani et al., 2018; Fujitani, Zhang, Fujiki, Fujihara, & Yamashita, 2017; Hayashi et al., 2017) . In neurons, this regulation is the basis for the transmission and integration of synaptic inputs, and establishes adequate responses for the development, plasticity, and survival of neurons (Compagnucci et al., 2015; Kurian et al., 2018; Pederick et al., 2018) .
PCDH19 belongs to δ2 subgroup of nonclustered desmosomal cadherins and PCDHs, which also contain PCDH8, PCDH10, PCDH12, PCDH17, and PCDH18. This is also the basis for our conservative analysis. PCDH19 consists of six exons with a total length of 9,765 nucleotides and is located on chromosome Xq22.3. PCDH19 which with 1,148 amino acids is composed of a signal sequence, six extracellular cadherin (EC) repeats, a transmembrane domain and a cytoplasmic region with conserved cytoplasmic domain (CM) 1 and CM2. Exon 1 is translated into the whole extracellular and transmembrane domain, as well as a small part of the cytoplasmic domain. The rest is encoded by exon 2-6. Exons 5 and 6 encode CM1 and CM2, respectively. The reported mutation types include missense, nonsense, insertion or deletion of bases, splicing, deletion of fragments or whole genes, and deletion of other adjacent genes (Depienne et al., 2011; Vincent et al., 2012) . Seven of the eight-point mutations in our study were in exon 1, including four frameshift mutations, two missense mutations, one in-frame mutation; while one mutation occurred in exon 6, just like the reported mutations which occurred mostly in exon 1 (Kolc et al., 2019) . The intracellular C terminal tail of PCDH19 contains the conserved motifs CM1 and CM2, and the Wiskott-Aldrich syndrome protein (WASP) family (Chen et al., 2014) , these domains anchor on the cytoskeleton and integrate with intracellular signal transduction pathways. So C.2859_2860insT in exon 6 may play a pathogenic role by affecting intracellular signal transduction. But there is no intron after the premature termination codon this variant generates so the PCDH19 mRNA is unlikely to be degraded by nonsense-mediated mRNA decay, and we did not have enough evidences to prove that this variant affects mRNA or protein stability. So according to the ACMG standard, it should be likely pathogenic (LP), but because of its location, it may be just considered as variant of undetermined significance (VUS). The girl with this mutation had fever sensitivity, clustered transient partial seizures, and developmental retardation, the clinical characterization was highly consistent with PCDH19-GCE. So, we kept this VUS site which may be a pathogenic mutation. With the increasing reports of this kind of variants in the future may help us better understand the pathogenesis of PCDH19-GCE. Some evidences proved the cytoplasmic region of PCDH19 which bind to GABA A receptor (GABA A R) alpha subunit can regulate the availability of receptor surface which may be involved in the regulation of intracellular transport of GABA A R (Bassani et al., 2018; Gerosa et al., 2019) . Other studies have found that the level of allopregnanolone (AP) in PCDH19 female epilepsy patients was decreased (Tan et al., 2015) , and AP is the most effective positive regulator of GABA A R which mediates fast inhibitory neurotransmission in the brain, so PCDH19 as a key modulator of GABAergic transmission and may suggest new pathogenic mechanisms. Six mutations were found in EC1-4 (6/8, 75%), including two missense mutations, which are highly conserved in orthologs and in paralogs of PCDHs. The EC1-4 repeats of PCDH19 have been identified as the minimal adhesive unit involved in the generation of a trans adhesive interface. These repeats interact in antiparallel PCDH19 dimer (forearm handshake model) to play the role of adhesion and mediation (Cooper, Jontes, & Sotomayor, 2016) .
In this study, Seven PCDH19 mutations of the 10 probands were de novo, three mutations were inherited from fathers, and sporadic new mutations accounted for the majority, which was the main mutation type, consistent with the literature (Duszyc et al., 2015) .
And, our report found four novel mutations which expand the spectrum of PCDH19 mutations associated with epilepsy in females. All the patients in the study were female, with onset age ranging from 5 months to 20 years old, later than the 6 months to 3 years old reported in the literature (Smith et al., 2018) . In our study, the patients with the onset age older than 3 years (5/16, 31.25%) were mainly the first and second generations of the families. So PCDH19-GCE does not only onset in infancy, but it also can occur late in adulthood, and the late-onset patients may have mild clinical phenotype.
Except for two deaths, other patients had the characteristics of cluster, transient focal seizures, or GTCS. It was found that 70.5% of children had terrible screams when focal seizures occurred (Antelmi et al., 2012; Marini et al., 2012) , the proportion in this study was 35.71%, which was lower than that. (Higurashi et al., 2013; Lotte et al., 2016; Trivisano, Specchio, & Vigevano, 2015) .
Corticosteroids have been reported to be effective in the treatment of acute cluster termination in a patient with PCDH19-GCE, then the hypothesis that blood-brain barrier dysfunction exists in PCDH19-GCE patients has been proposed (Bertani et al., 2015; Higurashi et al., 2015) . However, remission is only temporary and epileptic seizures recur. After discovering that the level of allopregnanolone and steroidogenesis decreased (Tan et al., 2015; Trivisano et al., 2017) , clinical trials began with ganaxolone, a synthetic analog of isoprogesterone (Tan et al., 2015) . Surgical excision can reduce seizures in patients with cortical dysplasia (Kurian et al., 2018 AEDs. This may suggest that if we met a PCDH19 family in clinic, the medication characteristics of proband in the family can guide the treatment of other patients in the same family. But the number of samples is too small, so that is just our guess. During the recent follow-up, the seizure-free interval ranged from 3 months to 13 years. Two patients had remission time longer than 3 years, with remission ages of adolescence and adulthood, respectively. Specchio et al. (2011) believed that AEDs could not control the cluster seizures in children, and the decrease in seizures with age may be related to the decrease in febrile diseases.
In conclusion, PCDH19 mutations can be inherited or de novo.
PCDH19 mutations-related epilepsy has incomplete penetration rate and phenotypic heterogeneity. The phenotypes of PCDH19 mutations include PCDH19-GCE with or without mental retardation, psychosis, and male asymptomatic carriers. PCDH19-GCE is characterized by clustered transient GTCS and focal seizures, and fever sensitivity. The onset age of PCDH19-GCE can vary from childhood to adulthood. And, our report expands the spectrum of PCDH19 mutations associated with epilepsy in females. We thank the patients and their family members for taking part in this study.
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